Related Experiment Video
Updated: Feb 17, 2026

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Meeting the Challenges of Cytokine Administration During Nuclear Incident Response
Dana C Tedesco1, Suzanne Wright2, Kenneth D Cliffer3
1Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Washington, DC, USA.
Abstract:
Dr. C. Norman Coleman initiated the establishment of a working group within the Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services, to explore ways in which federal planning and guidance could better foster effective and efficient nuclear detonation response, with initial attention to cytokine use in the public health and medical response. Dr. Coleman recognized the difference between planning guidance (what to do) and a strategy (how to do it). He developed actionable strategies to improve our nation's nuclear preparedness, including scarce resources triage protocols,1 cytokine and evacuation priorities,2 and the Exposure And Symptom Triage (EAST) tool.3 Despite his absence and in his spirit, this working group, nicknamed "The Solutions Lab," is continuing the work on actionable strategies for nuclear preparedness.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Myocarditis IV: Nursing Management
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies

